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Abstract
Background: The HIV pandemic raised the potential for facultative-pathogenic mycobacterial species like,
Mycobacterium kansasii, to cause disseminating disease in humans with immune deficiencies. In contrast, non-
pathogenic mycobacterial species, like M. smegmatis, are not known to cause disseminating disease even in
immunocompromised individuals. We hypothesized that this difference in phenotype could be explained by the
strong induction of an innate immune response by the non-pathogenic mycobacterial species.
Results: A comparison of two rapid-growing, non-pathogenic species (M. smegmatis and M. fortuitum) with two
facultative-pathogenic species (M. kansasii and M. bovis BCG) demonstrated that only the non-pathogenic bacteria
induced strong apoptosis in human THP-1 cells and murine bone marrow-derived macrophages (BMDM) and
dendritic cells (BMDD). The phospho-myo-inositol modification of lipoarabinomannan (PI-LAM) isolated from non-
pathogenic species may be one of the cell wall components responsible for the pro-inflammatory activity of the
whole bacteria. Indeed, PI-LAM induces high levels of apoptosis and IL-12 expression compared to the mannosyl
modification of LAM isolated from facultative-pathogenic mycobacteria. The apoptosis induced by non-pathogenic
M. smegmatis was dependent upon caspase-3 activation and TNF secretion. Consistently, BALB/c BMDM responded
by secreting large amounts of TNF upon infection with non-pathogenic but not facultative-pathogenic
mycobacteria. Interestingly, C57Bl/6 BMDM do not undergo apoptosis upon infection with non-pathogenic
mycobacteria despite the fact that they still induce an increase in TNF secretion. This suggests that the host cell
signaling pathways are different between these two mouse genotypes and that TNF is necessary but not sufficient
to induce host cell apoptosis.
Conclusion: These results demonstrate a much stronger induction of the innate immune response by non-
pathogenic versus facultative-pathogenic mycobacteria as measured by host cell apoptosis, IL-12 and TNF cytokine
induction. These observations lend support to the hypothesis that the strong induction of the innate immune
response is a major reason for the lack of pathogenicity in fast-growing mycobacteria.
Background
Facultative-pathogenic mycobacterial species cause disse-
minating mycobacterial infections in humans that are
defective in the acquired immune response (IR). For
example, M. kansasii and M. avium are often found as
opportunistic pathogens in immunosuppressed individuals
due to AIDS. In contrast, non-pathogenic mycobacteria of
the M. fortuitum and M. smegmatis group do not cause
disseminating disease even in immunosupressed indivi-
duals [1]. Therefore, we hypothesized that the inability of
non-pathogenic species to cause disease could be due to
their strong capacity to induce an innate IR, which is suffi-
cient to defend against these species of mycobacteria even
in individuals with defective acquired immunity.
The capacity of infected macrophages to undergo
apoptosis after infection is an efficient mechanism of
innate IR against mycobacteria [2]. Indeed, the induction
of apoptosis of infected macrophages may induce direct
killing of intracellular mycobacteria [3,4]. In addition,
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mycobacteria contained in apoptotic bodies can be taken
up via phagocytosis by uninfected bystander macro-
phages which are then able to kill the bacteria more effi-
ciently [5]. Furthermore the importance of macrophage
apoptosis for the IR was underscored by the recent find-
ings that host susceptibility or resistance to mycobacter-
ial infections could be linked to the capacity of the
infected macrophages to undergo necrosis or apoptosis,
respectively [6]. Consistently, virulent M. tuberculosis
strains express proteins implicated in inhibiting host cell
apoptosis such as the superoxide dismutase A (SodA),
catalase G (KatG) and NuoG which is part of the NDH-
1 protein complex. The deletion of any of these genes
strongly attenuates the virulence of the bacteria suggest-
ing that host cell apoptosis inhibition is a virulence
pathway [7-9].
In primary human alveolar macrophages the faculta-
tive-pathogenic mycobacteria (M. kansasii and M. bovis
BCG) induced significantly more apoptosis then four
different virulent strains of M. tuberculosis after 5 days
of infection [10]. Interestingly, M. smegmatis induces
significant apoptosis in differentiated human THP-1
cells after only 24 h [8], suggesting the presence of
potent mycobacterial ligands capable of inducing host
cell signaling. The phospho-myo-inositol-lipoarabino-
mannan (PI-LAM) isolated from the cell wall of an uni-
dentified fast-growing mycobacterial species, also
referred to Ara-LAM, could be one such ligand, since it
has been shown to induce host cell apoptosis [11,12].
The host cell cytokine response during mycobacterial
infections is regulated by mitogen activated protein
kinase (MAPK) pathways [13]. The facultative-patho-
genic M. avium induced a profoundly different host
cell signaling response when compared to the non-
pathogenic M. smegmatis [14]. In particular, the infec-
tion with M. smegmatis led to an increased p38 and
ERK1/2 MAPKs activity in BMDMs which was neces-
sary for increased TNF secretion [14]. Furthermore,
this increase in MAPKs was dependent upon pro-
longed stimulation of calmodulin/calmodulin kinase
and cAMP/protein kinase A pathways [15]. In addition,
sphingosine kinase, phosphoinositide-specific phospho-
lipase C and conventional protein kinase C were all
implicated in M. smegmatis-induced activation of
Erk1/2 [16]. One downstream target of the MAPK p38
was determined to be the transcription factor cyclic
AMP response element binding protein (CREB) which
was more activated in M. smegmatis-infected cells [17].
In order to understand why non-pathogenic mycobac-
teria are strongly attenuated we compared their capacity
to induce an innate IR to that of facultative-pathogenic
mycobacteria. The induction of apoptosis and the stimu-
lation of TNF expression in macrophages were analyzed
and in both cases the macrophage response was much
stronger for the non-pathogenic mycobacteria than the
facultative-pathogenic mycobacteria. The induction of
TNF secretion was important for the increase in cas-
pase-3-dependent host cell apoptosis in BMDM.
Furthermore, purified PI-LAM of the nonpathogenic
mycobacterial species interacted with the TLR-2 and
induced apoptosis and IL-12 p40 expression, whereas
the purified Man-LAM of the facultative-pathogenic
mycobacteria had no such activity. Altogether, faculta-
tive-pathogenic mycobacteria induce less of an innate
immune response in macrophages relative to non-patho-
genic mycobacteria.
Results and Discussion
Non-pathogenic mycobacteria induce increased host cell
apoptosis
In order to test the apoptotic response of macrophages
following infection with facultative-pathogenic compared
to non-pathogenic mycobacteria, we used bone marrow-
derived macrophages (BMDM) from BALB/c mice and
infected them with M. smegmatis, M. fortuitum, M.
bovis BCG, or M. kansasii for two hours. We then incu-
bated the macrophages in infection medium with genta-
mycin for an additional twenty hours. The percentage of
apoptotic cells was determined by quantifying the frac-
tion of hypodiploid positive cells via flow cytometry
(Figure 1A). 75-80% of BMDMs infected with M. smeg-
matis and M. fortuitum were hypodiploid positive which
was significantly different (p < 0.001) from BMDMs
infect with facultative-pathogenic mycobacteria (Figure
1B). Indeed, BMDMs infected with BCG and M. kansa-
sii did not show any significantly increased levels of
apoptosis compared to the untreated control cells dur-
ing the course of this short term infection (p > 0.05;
Figure 1B).
This difference in host cell apoptosis induction is con-
served in human macrophage-like cells (THP-1 cell line)
which are a good model for the behavior of primary
human alveolar macrophages in response to mycobac-
terial infections [18]. PMA-differentiated THP-1 cells
were infected and incubated for an additional 20 h at
which time the percentage of apoptotic cells was deter-
mined using the TUNEL assay as previously described
[8]. Figure 2 shows that M. smegmatis-infected cells
underwent about a 4 fold increase in apoptosis (~40%
total, p < 0.005) and M. fortuitum infection resulted in a
5-6 fold increase (~55% total, p < 0.001) when com-
pared to cells infected with facultative pathogenic myco-
bacteria (~10%) (Figure 2). This difference in apoptotic
response between non-pathogenic and facultative-patho-
genic mycobacteria supports our hypothesis that non-
pathogenic mycobacteria induce a very potent innate
immune response when compared to facultative-patho-
genic mycobacteria.
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The induction of macrophage apoptosis has been
implicated in innate host defense against mycobacteria
[2]. The importance of apoptosis in innate immune
response was demonstrated by the attenuation of a pro-
apoptotic Mtb mutant in immunodeficient SCID mice
[8]. In a previous study it was demonstrated that faculta-
tive-pathogenic mycobacteria (M. kansasii and M. bovis
BCG) induce more apoptosis then virulent mycobacteria
in primary alveolar macrophages after five to seven days
of infection [10]. Interestingly, we demonstrated that M.
smegmatis induces apoptosis of THP-1 cell already after
16 h of infection [8]. The current results thus extend
this initial observation to another fast-growing, non-
pathogenic mycobacterial species. They indicate that the
pro-apoptotic capacity might be a general characteristic
of this group of mycobacteria but it would clearly be
desirable to analyze more strains of mycobacteria in
order to support this generalization.
The PI-LAM cell wall component of non-pathogenic
mycobacteria mediates pro-inflammatory response
Pathogen associated molecular patterns (PAMP) interact
with pathogen pattern recognition receptors (PRR) to
induce host immune responses [19]. Toll-like receptors
bind to bacterial and viral derived ligands and may
induce host cell apoptosis [20,21]. The mycobacterial
cell wall contains several components with immunomo-
dulatory activities [22,23]. In particular, lipoarabinoman-
nan (LAM) and its differential terminal modifications
with mannose caps (Man-LAM) versus phosphomyo-
inositol caps (PI-LAM) have been extensively investi-
gated [24,25]. Nevertheless, the PI-LAM (named
Ara-LAM) in most previous studies used was derived
from an unidentified, fast-growing mycobacterium [26].
Here we extended the analysis to include two PI-LAMs,
kindly provided by Drs. J. Nigou and G. Puzo, purified
from the non-pathogenic, fast-growing M. smegmatis
and M. fortuitum [27]. THP-1 cells were treated with
20 μg/ml of the different LAMs for 24 h and the per-
centage of apoptotic cells was determined using
Annexin-V assay as previously described [12]. The PI-
LAM of both non-pathogenic mycobacteria induced
approximately a twofold increase in apoptosis (~35-40%)
when compared to the Man-LAM from the facultative-
pathogenic mycobacteria (~20%) which was a significant
difference with p < 0.001 (Figure 3A). In addition, the
Figure 1 Differences in apoptosis induced by facultative-
pathogenic versus non-pathogenic mycobacteria in primary
murine macrophages. Differentiated BALB/c BMDMs were infected
at an MOI of 10:1 with M. smegmatis (Msme), M. fortuitum (Mfort),
M. kansasii (Mkan), M. bovis BCG or left untreated (UT). The
percentage of apoptotic cells was determined using a propidium
iodide based staining protocol to detect the population of
hypodiploid cells via flow cytometry at 20 h after infection.
Representative histograms are shown in A. B. The average and
standard deviation of three independent experiments is shown. For
this and all subsequent figures asterisks indicate statistically
significance with * = 0.05>p > 0.01, ** = 0.01>p > 0.001 and *** =
p < 0.001 which was determined by using one way ANOVA using
GraphPad Prism5.0 software.
Figure 2 Difference in apoptosis induction between facultative
and non-pathogenic mycobacteria in a human macrophage
cell line. PMA-differentiated THP-1 cells were infected with
indicated mycobacteria and the amount of apoptosis was
determined 20 h after infection using TUNEL assay and flow
cytometry on duplicate samples. The results are the mean and
standard deviation of three independent experiments.
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pro-inflammatory potential of the PI-LAMs was ana-
lyzed using an IL-12 p40 reporter cell line [12]. The p40
promoter was activated in 60-80% of the cells treated
with PI-LAM when compared to only 10-20% of
the cells treated with either Man-LAM (p < 0.001;
Figure 3B). The induction of the IL-12 reporter by the
PI-LAMs was similar to the promoter activity induced
by LPS (~80%), a well-characterized TLR-4 ligand that
efficiently induces IL-12 secretion.
Another reporter cell line was used to study the inter-
action of PI- and Man-LAM with TLR-2 and TLR-4
[28]. In CHO cells, transfected with either human TLR-
2 or TLR-4, the induction of TLR signaling was mea-
sured by flow cytometry via cell surface staining of the
CD25 molecule which is under control of a promoter
inducible by TLR-2 and TLR-4 signaling (Figure 4) [28].
The PI-LAMs both induced an 8 to 10 fold increase in
CD25 expression when compared to untreated cells,
whereas both Man-LAM species only induced maximal
3 fold inductions (p < 0.05 for Msme PI-LAM and p <
0.001 for Mfort PI-LAM; Figure 4A). All of the LAMs
had minimal interaction with TLR-4 (less than 2 fold
induction), when compared to LPS-treated cells which
increased CD25 expression about 7 fold (Figure 4B).
Overall, the results of the current study are very
consistent with reported results demonstrating that the
PI-LAM of an unidentified, fast-growing mycobacterial
species induces host cell cytokine secretion and apop-
tosis [24]. We extended these results to include
PI-LAM of M. smegmatis and another PI-LAM of
M. fortuitum [27], both of which induced host cell
apoptosis and cytokine secretion. These results thus
confirmed the general principle that PI-modified
LAMs are pro-inflammatory. Furthermore, both of
Figure 3 PI-LAM of fast-growing mycobacteria induces
apoptosis and IL-12 gene expression in macrophages. A.
Differentiated human THP-1 cells were not treated (UT) or
incubated with the indicated lipoglycans at 20 μg/ml for 24 h. The
percentage of apoptotic cells was determined as Annexin-V-
Alexa488-positive and propidium iodide-negative cells out of 10,000
analyzed cells by flow cytometry. B. The induction of Il-12 gene
expression was analyzed by incubating a murine macrophage
(RAW/pIL-12-GFP) reporter cell line which has the IL-12p40
promoter in front of the GFP gene, with the indicated lipoglycans
for 16 h. GFP-expression was analyzed on 5,000 cells and the mean
and standard deviation of three independent experiments is shown.
Figure 4 PI-LAMs activate cells in a TLR-2-dependent manner. A.
CHO/CD14/TLR-2 and B. CHO/CD14/TLR-4 reporter cell lines were
incubated with the indicated lipoglycans at 20 μg/ml or LPS at 1 μg/
ml for 16 h. Cellular activation was measured by determining the
expression of CD25 at the cell surface by using anti-CD25
monoclonal antibodies and flow cytometry. The mean fluorescence
intensities were determined and the fold induction over untreated
cells was calculated and the mean and standard deviation of three
independent experiments is shown.
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these PI-LAMs interact with macrophage TLR-2 but
not TLR-4 receptors suggesting that the PI-component
is the ligand of the TLR-2. Interestingly, despite the
existence of a mycolic acid rich outermembrane in
myocbacteria, it seems that LAM are still able to reach
the outermost layers of the envelop to be exposed at
the cell surface of the bacterium and thus exert their
function as immunomodulins [29-31].
Non-pathogenic mycobacteria induce apoptosis via TNF
and caspase-3 signaling pathways
TNF is a central pro-inflammatory cytokine that med-
iates and regulates innate immunity. TNF binding to
TNF-R1 may lead to activation of NF- B, followed by
gene transcription, production of inflammatory media-
tors and survival proteins. On the other hand, TNF
binding may also initiate JNK protein kinase activation
followed by activation of caspase-8 and downstream
effector caspases such as caspase-3 resulting in apoptosis
of the cell [32].
In order to analyze the importance of TNF in apopto-
sis induction by the non-pathogenic mycoabcteria
BALB/c BMDMs were infected with M. smegmatis, M.
fortuitum, BCG, and M. kansasii at three MOIs (1:1, 3:1,
and 10:1) for two hours and then incubated in medium
with gentamycin for an additional 20 hours. The
amounts of secreted TNF in the culture supernatants
were measured using ELISA. BALB/c macrophages
infected with M. smegmatis secreted 10 to 18 fold more
TNF than macrophages infected with BCG or M. kansa-
sii, which did not secrete significant amounts of TNF.
M. fortuitum infected macrophages also secreted around
6 fold more TNF than BCG and M. kansasii infected
cells (Figure 5A). The impact of non-pathogenic
mycoabcteria on IL-12 gene expression was also much
higher when compared to facultative-pathogenic myco-
bacteria (Figure 5B). Indeed, infection of the IL-12 p40
reporter cell line [12] at an MOI of 10:1 with M. smeg-
matis or M. fortuitum resulted in p40 promoter-driven
GFP expression in about 30% of the cells, whereas only
5-10% of the cells became GFP positive after infection
with the facultative-pathogenic mycobacteria (p < 0.001,
Figure 5B). In conclusion, our results demonstrate a
stronger induction of two pro-inflammatory cytokines
(TNF and IL-12) after macrophage infection with two
species of non-pathogenic mycobacteria when compared
to facultative-pathogenic mycobacteria.
We showed that non-pathogenic mycobacteria induce a
strong apoptotic response and TNF secretion in BALB/c
macrophages (Figures 1B and 5A) when compared to
facultative-pathogenic mycobacteria. Apoptosis of eukar-
yotic cells can follow either a caspase-dependent or cas-
pase-independent pathway. All caspase-dependent
pathways lead to activation of effector caspase-3/6/7 [33].
In order to determine which pathway was involved in the
macrophage apoptotic response to non-pathogenic
mycobacterial infection, we pretreated BALB/c BMDMs
with caspase-3 inhibitor, TNF neutralizing antibody, pen-
toxifylline (a chemical inhibitor of TNF synthesis), the
appropriate controls, or left the cells untreated then
infected them with M. smegmatis at MOI of 10:1 for 2
hours. The cells were then incubated in media with gen-
tamycin for an additional 20 hours. Host cell apoptosis
was determined on 10,000 cells using the hypodiploid
flow cytometry assay. In a representative experiment,
Figure 5 Differences in TNF secretion and IL-12 induction
between facultative-pathogenic and non-pathogenic
mycobacteria infected macrophages. A. BALB/c BMDMs were
infected at MOIs of 1:1, 3:1, and 10:1 with M. smegmatis (Msme), M.
fortuitum (Mfort), M. kansasii (Mkan), M. bovis BCG, or left untreated
(UT). Cells were infected in triplicates for 2 h then washed and
incubated in infection media with 100 μg/ml gentamycin for an
additional 20 h. Culture supernatants were then collected and the
amounts of secreted TNF was determined using ELISA. The values
are the mean and standard deviation of triplicate readings and they
are representative of three independent experiments. B. The
induction of Il-12 gene expression was analyzed by infecting RAW/
pIL-12-GFP macrophages with the indicated bacteria for 2 h at an
MOI of 10:1. The GFP-expression was analyzed on 5,000 cells 16 h
later and the mean and standard deviation of three independent
experiments is shown.
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cells treated with the caspase-3 inhibitor showed a signif-
icant decrease in apoptosis (1.2%) when compared to the
untreated M. smegmatis infected control (20.0%) and to
cells treated with an inactive chemical analogue of the
caspase-3 inhibitor (16.8%) (Figure 6). TNF neutralizing
antibody (1.1%) or pentoxifylline treated cells (5.5%) also
showed a very significant decrease in apoptosis compared
to the untreated (20.0%) or nonspecific antibody treated
cells (21.0%) (Figure 6). These results demonstrate that
that apoptosis of BMDMs induced by nonpathogenic
mycobacteria is dependent upon TNF secretion and cas-
pase-3 activation.
The increased cytokine secretion by macrophages upon
infection with non-pathogenic M. smegmatis versus
facultative-pathogenic M. avium has been demonstrated
in human and murine macrophages and human neutro-
phils [15,34,35]. Our study builds upon these previous
results by extending the analysis to include several non-
pathogenic versus several facultative-pathogenic myco-
bacteria. We underscore that the strong pro-inflamma-
tory response elicited by macrophage might be a more
general characteristic of non-pathogenic mycobacteria.
The increase of TNF secretion induced by M. smegmatis
in murine BMDM is dependent upon stimulation of the
cAMP/protein kinase A pathway which results in pro-
longed ERK1/2 activation [15]. Furthermore, M. smegma-
tis infection leads to increase in TNF and NOS2
promoter activity but not infection with M. avium
[15,36]. The present study also extends upon these pre-
vious findings by linking the increase in TNF secretion to
pro-apoptotic capacity of the non-pathogenic mycobac-
teria (Figure 6) and characterizing this apoptosis pathway
as being caspase-dependent (Figure 6).
Non-pathogenic mycobacteria do not induce apoptosis in
C57Bl/6 BMDM
We demonstrated that non-pathogenic mycobacteria
induce a strong apoptotic response and TNF secretion
in BALB/c macrophages (Figures 1 and 5) when com-
pared to facultative pathogenic mycobacteria. We also
demonstrated that TNF plays a role in this apoptotic
response (Figure 6). We therefore intended to further
clarify the role of TNF by using TNF knock-out mice.
Nevertheless, to our surprise we determined that
BMDMs from C57Bl/6 wild-type mice, which is the
genetic background of the TNF deficient mice, did not
undergo apoptosis upon infection with non- and faculta-
tive-pathogenic mycobacteria using two different apop-
tosis detection assays (p > 0.05; Figure 7A and 7B).
Interestingly, non-pathogenic mycobacteria still induced
a significant increase of TNF secretion in the C57Bl/6
macrophages (Figure 7C). Indeed, they secreted around
5 fold more TNF when infected with M. smegmatis and
M. fortuitum compared to infections with BCG and
M. kansasii, the latter of which did not induce the
secretion of any detectable amounts of TNF (Figure 7C).
These results demonstrate that the apoptotic response
upon infection with non-pathogenic mycobacteria is
dependent on the genotype of the host. The total
amount of TNF secreted after M. smegmatis infection is
reduced in C57Bl/6 versus BALB/c BMDMs (Figures 5A
Figure 6 Macrophage apoptosis induction by a non-
pathogenic mycoabcterium is caspase-3 and TNF-dependent.
BMDMs from BALB/c mice were left untreated and uninfected (UT)
or infected with M. smegmatis and then either left in medium
(Msme) or treated with caspase-3 inhibitor (C3I), nonspecific
chemical analog (C3I-A) neutralizing TNF antibody (TNF-Ab),
nonspecific control Ab (Co-Ab) and TNF synthesis inhibitor
pentoxifylline (PTX). The percentage of apoptotic cells out of 10,000
total cells was determined after 20 h using the hypodiploid PI flow
cytometry assay and a representative histogram of two independent
experiments performed in duplicates is shown.
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Figure 7 Mycobacteria do not induce rapid apoptosis in BMDM originating from C57Bl/6 mice. A. Differentiated C57Bl/6 BMDMs were
infected at an MOI of 10:1 with M. smegmatis (Msme), M. fortuitum (Mfort), M. kansasii (Mkan), M. bovis BCG or left untreated (UT). The
percentage of apoptotic cells was determined using a propidium iodide based staining protocol to detect the population of hypodiploid cells
via flow cytometry at 20 h after infection. B. C57Bl/6 BMDMs were infected as in A. or incubated with staurosporine (ST) and the amount of
apoptosis was detected using TUNEL staining and flow cytometry analysis. C. Macrophages were infected at MOIs of 1:1, 3:1, and 10:1 with M.
smegmatis (Msme), M. fortuitum (Mfort), M. kansasii (Mkan), M. bovis BCG, or left untreated (UT). Culture supernatants of triplicate wells were
collected after 20 h and the amounts of secreted TNF was determined using ELISA. In A. and B. the data shown is the mean and standard
deviation of three independent experiments. In C. the values are the mean and standard deviation of triplicate readings of one experiment and
they are representative of three independent experiments.
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and 7C). For example at an MOI of 10:1 M. smegmatis
induces 16.7 ± 2.7 ng/ml in BALB/c macrophages but
only 4.4 ± 0.7 ng/ml in C57Bl/6 (p < 0.01). This could
be interpreted as evidence for the role of decreased TNF
secretion in the absence of M. smegmatis induced apop-
tosis of C57Bl/6 BMDMs. Nevertheless, infection of
BMDMs of either mouse strain by M. fortuitum results
in very similar induction of TNF secretion of 6.2 ±
2.0 ng/ml and 4.9 ± 1.1ng/ml in BALB/c and C57Bl/6,
respectively (p > 0.05; Figures 5A and 7C) but still
M. fortuitum just like M. smegmatis only induces apop-
tosis in BALB/c BMDMs but not C57Bl/6 cells (Figures
1B and 7A). We hypothesize thus that a certain amount
of TNF secretion is necessary but not sufficient to med-
iate apoptosis induction of BMDMs. In a recent study
we demonstrated a similar dissociation between induc-
tion of TNF secretion and host cell apoptosis [7]. A
pro-apoptotic Mtb mutant still induced TNF secretion
but not host cell apoptosis in BMDMs lacking func-
tional phagocyte NADPH oxidase (NOX2). It is thus
intriguing to speculate that BALB/c and C57Bl/6 NOX2
enzymes react differently upon phagocytosis with non-
pathogenic mycobacteria with the former inducing a
stronger, prolonged activity resulting in a greater
increase in ROS. It could be that this increase in ROS
would tip the balance of the autocrine TNF-signaling
towards apoptosis via increased JNK activation [37].
Differences in apoptosis induced by facultative-
pathogenic and non-pathogenic mycobacteria in BALB/c
and C57BL/6 dendritic cells
M. tuberculosis resides primarily in alveolar macro-
phages of infected humans. Nevertheless, at least in the
lungs of infected mice, a large percentage of M. tubercu-
losis infected cells were found to be dendritic cells [38].
Consequently, we examined whether the difference in
the apoptotic response between non-pathogenic myco-
bacteria and facultative-pathogenic mycobacteria
observed in macrophages also manifests itself in bone-
marrow-derived dendritic cells (BMDD). Thus BALB/c
and C57BL/6 BMDDs were infected with GFP-expres-
sing M. smegmatis and BCG strains for two hours, then
washed and incubated in media with gentamycin for an
additional 20 hours. The rate of infection was similar
across all conditions and cells as determined by flow
cytometry (GFP fluorescence intensity shifts) and colony
forming units on agar plates (data not shown). The
number of hypodiploid positive cells was quantified
using the PI-based flow cytometry assay described
before. M. smegmatis infected C57BL/6 and BALB/c
dendritic cells showed a significant increase in apoptosis
(about 60% in both) when compared to BCG and unin-
fected cells (p < 0.0001; Figure 8A and 8B). Interestingly,
in contrast to BMDMs in BMDDs the facultative-myco-
bacteria BCG induced a significant increase in apoptosis
after one day of infection of about 15% for C57Bl/6 and
25% for BALB/c compared to about 5% in untreated
cells (p < 0.0001; Figure 8A and 8B). Our results suggest
that BMDDs are inherently more susceptible for under-
going apoptosis upon infection with facultative myco-
bacteria than macrophages in BALB/c (compare Figures
1B and 8B). They also indicate that there is a profound
difference between bone marrow-derived macrophages
and dendritic cells in C57Bl/6 mice in regard to apopto-
sis induction upon infection with non-pathogenic
Figure 8 Differences in apoptosis induced by facultative-
pathogenic and non-pathogenic mycobacteria in BALB/c and
C57Bl/6 dendritic cells. C57Bl/6 (A) and BALB/c (B) bone
marrowderived dendritic cells (BMDD) were infected at an MOI of
10:1 with M. smegmatis (Msme), M. bovis BCG or left untreated (UT).
After 2 h cells were washed and incubated in infection media with
100 μg/ml gentamycin for an additional 20 h. The percentage of
hypodiploid cells of a total of 10,000 cells was determined using the
flow cytometry. The values of the mean and standard deviation of
three independent experiments are shown.
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mycobacteria (compare Figures 7A and 8A). This differ-
ence could be due to the inherently increased activity of
NOX2 enzyme complex in dendritic cells when com-
pared to macrophages [39]. NOX2 in dendritic cells is
thought to keep the phagosome at a more neutral pH in
order to facilitate generation antigenic peptides for cross
presentation [39]. One of the consequences of increase
NOX2 activity is an accumulation of reactive oxygen
species (ROS) and increases in ROS levels have been
shown to shift the balance of TNF-R1 signaling in favor
of JNK activation and the induction of apoptosis [32,37].
In order to address the potential role of ROS mediated
apoptosis induction in C57Bl/6 derived BMDMs and
BMDDs, cells were infected as described before and the
amount of ROS was detected using dihydroethidium
(DHE) and quantified by flow cytometry (Figure 9).
Interestingly, in BMDMs only the zymosan control
induced any increase in ROS levels after 24 h of incuba-
tion (Figure 9A). In contrast, in the dendritic cells M.
smegmatis infection induced an important accumulation
of ROS when compared to zymosan and BCG infected
cells (Figure 9B). These results support the argument
that dendritic cells are more susceptible to infection-
induced apoptosis due to their capacity to generate high
levels of ROS due to sustained NOX2 activity when
compared to the rapid induction and inactivation of
NOX2 in macrophages [39].
Conclusions
We hypothesized that the attenuation of non-pathogenic
versus facultative-pathogenic mycobacteria could be
explained in part by their strong induction of an innate
immune response. Indeed, here we demonstrate that
two representative strains of non-pathogenic mycobac-
terial species induce a stronger inflammatory response
as measured by the cytokines TNF and IL-12. They also
induce an increased apoptotic response in BMDMs and
BMDDs. The PI-LAM and Man-LAM cell wall compo-
nents of non-pathogenic and facultative-pathogenic
mycobacteria, respectively, were analyzed. They could be
a reason for the increased innate immune response
since PI-LAM induces increased cytokine secretion and
apoptosis response when compared to Man-LAM. We
propose that the different mycobacterial species can be
characterized by the following three functional groups:
1) Nonpathogenic which have no mechanisms to inhibit
immune responses and contain a lot of PAMPs to
induce a response, 2) facultative-pathogenic mycobac-
teria have few if any mechanisms to inhibit host cell
immune responses but have evolved to mask some of
their PAMP so they do not induce a strong innate
response and finally 3) highly adapted virulent mycobac-




M. smegmatis strain (mc2 155) was obtained from Dr. Wil-
liam Jacobs Jr., and M. fortuitum strain (ATCC 6841) and
M. kansasii strain Hauduroy (ATCC 12478) were obtained
from the American Type Culture Collection http://www.
Figure 9 Differences in ROS response to mycobacterial
infection between C57Bl/6 macrophages and dendritic cells.
Cells were infected as described in figure 8 and ROS were detected
2 h after infection using dihydroethidium (DHE). A. BMDM or B.
BMDD left untreated (UT), infected with BCG, M. smegmatis (Msme)
or incubated with opsonized zymosan particles for 4 h or 24 h. The
increase in DHE mediated fluorescence (FL-2) was analyzed by flow
cytometry of 10,000 total cells. A representative of three
independent experiments is shown.
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atcc.org. M. bovis BCG Pasteur strain was obtained from
the Trudeau Culture Collection (Saranac Lake, New York,
United States). GFF-expressing BCG and M. smegmatis
were generated by subcloning the enhanced GFP gene
(Clonetech, http://www.clonetech.com) into the mycobac-
terial episomal expression vector pMV261. The resulting
plasmid (pYU921) was transfected into competent cells by
electroporation as previously described (Snapper et.al,).
M. smegmatis was cultured in LB broth with 0.5% glycerol,
0.5% dextrose, and 0.05% TWEEN-80. M. fortuitum,
M. kansasii, and M. bovis BCG were cultured in 7H9
broth with 0.5% glycerol, 0.5% dextrose, and 0.05%
TWEEN-80, and 10% ADC enrichment. For selective
media, 40 μg/ml kanamycin was added.
Bone marrow-derived macrophages and dendritic cells
Four to six weeks old BALB/c or C57BL/6 mice were
obtained from the National Cancer Institute. Mice were
used before twelve weeks of age and sacrificed by CO2
asphyxiation followed by cervical dislocation in accor-
dance with IACUC approved protocols. The anterior
limbs were flushed with DMEM supplemented with 2%
fetal calf serum. Flushed bone marrow cells were then
pelleted and treated with 1× red blood cells lysis buffer
(eBiosciences) for 10 minutes then washed with 1×
phosphate buffered saline. For macrophage differentia-
tion, Cells were then plated on Petri dishes in DMEM
medium supplemented with 10% heat inactivated fetal
calf serum, 15% L929 cell supernatant, 1% Penicillin/
Streptomycin, and 2% HEPES then incubated at 37°C/
5% CO2. Cells were supplemented with additional med-
ium on day three. On day 7, all non-adherent cells were
washed off and the remaining adherent bone marrow-
derived macrophages were seeded on appropriate plates
for infection.
To derive dendritic cells, cells were incubated in med-
ium as described for macrophages but containing 20 ng/
ml murine GM-CSF (Peprotech) instead of L929 super-
natant. 1 × 106 cells/well were added to 6 well plates
containing 2.5 ml medium and an additional 2.5 ml
medium/well was added on days 3, 6, and 9. All non-
adherent dendritic cells were collected and seeded on
appropriate plates for infection.
Cell cultures conditions and infection
For the apoptosis assays, 5 × 105 bone marrow-derived
macrophages or dendritic cells in DMEM supplemented
with 10% fetal calf serum, and 2% HEPES (infection
media) were seeded on each well of a 24 well plates.
Bacteria were grown to an OD600 ranging from 0.2 - 0.8,
passed through a 26 Gauge needle 3 times and allowed
to settle for 10 minutes. The infection was carried out
at a multiplicity of infection (MOI) of 1:1, 3:1, and 10:1
for 2 h in duplicate wells, after which extracellular
bacterial were removed by 3 washes using PBS. The
cells were then incubated in DMEM infection medium
supplemented with 100 μg/ml gentamycin (Invitrogen)
for 20 h and the apoptosis assay was performed.
TNF and IL-12 assays
For the TNF secretion assays, 2 × 105 bone marrow-
derived macrophages in DMEM infection media were
seeded onto each well of 12 well plates and infected
with bacteria as indicated above. The culture superna-
tants were then collected 20 h after incubation in infec-
tion media supplemented with 100 μg/ml gentamycin.
The amount of TNF in supernatants was then measured
via ELISA (BD Bioscience). The RAW IL-12 promoter
cell line was created and used to measure IL-12 p40
induction as described in great detail in our previous
publication [12].
TLR interaction assay
The Chinese hamster ovary (CHO) cells transfected with
the inducible membrane protein CD25 under control of
a region from the human E-selectin promoter contain-
ing nuclear fact-kB binding sites and expressing CD14
and either human Toll-like receptor 2 (TLR-2) or
human TLF-4 were created as described in [28] kindly
provided by Dr. D.T. Golenbock. Cells were used exactly
as described previously by our group [12].
Apoptosis assays
In most of the experiments the flow cytometry-based,
hypodiploid assay was used for the detection of apopto-
sis after infection of bone marrow-derived macrophages
and dendritic cells. Cells were collected after infection,
pelleted and resuspended in propidium iodine (PI)/
RNase buffer (BD Pharmingen) for 20 min and the per-
centage of hypodiploid positive cells was determined by
flow cytometry in duplicates in the FL-2 channel at 580
nm (FACS-Calibur, BD Biosciences). The TUNEL assay
was performed as suggested by the manufacturer
(Roche) and described previously [8]. The apoptosis
induction mediated by lipoglycanes was analyzed via
AnnexinV-Alex488 (Molecular Probes) and PI double
staining and flow cytometry as described previously [12].
Caspase inhibition and TNF neutralization assays
BMDMs from BALB/c mice were treated with a pan-
caspase-3/6/7 inhibitor (100 μM), caspase-3 inhibitor
negative control (100 μM) (both from Calbiochem), anti
murine TNF neutralizing antibody (5 μg/ml), isotype
control antibody (5 μg/ml) (both from BD Bioscience),
or pentoxifylline (Sigma, 100 μg/ml) for 1 h at 37°C/5%
CO2 then infected with M. smegmatis at MOI 10:1 for 2
h as described above. Cells were then washed 3 times in
PBS and incubated for an additional 20 h in DMEM
Bohsali et al. BMC Microbiology 2010, 10:237
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infection media supplemented with the appropriate inhi-
bitors and controls mentioned above and the apoptosis
assay was performed.
ROS detection assay
Reactive oxygen species in BMDM and BMDD cells
were detected at 2 h post infection using the ROS sensi-
tive dye dihydroethidium (DHE) (Invitrogen). BMDM or
BMDD cells were deprived of L929 supernatant or
rGM-CSF respectively 16 hrs prior to infection and
maintained in cytokine free media without phenol red
for the length of the experiment. Post infection, cells
were washed once in HBSS and then incubated in 2 μM
DHE for 15 minutes. Cells were washed 3 times with
HBSS, fixed with 4% paraformaldehyde and analyzed by
flow cytometry.
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